Keryx Biopharm Inc (KERX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KERX | TNYA | PGEN | ||
| Company | Keryx Biopharm Inc | Tenaya Therapeutics Inc | Precigen Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.44 | 4.59 | 1.3800 | ||
| High | 3.46 | 4.78 | 1.4700 | ||
| Low | 2.96 | 4.28 | 1.3783 | ||
| Last | 3.36 | 4.27 | 1.4250 | ||
| Change | -0.07 | -0.13 | +0.0550 | ||
| % Change | -2.04% | -2.95% | +4.01% | ||
| Volume | 2,596,000 | 257,847 | 541,709 | ||
| 20-Day Average Volume | 1,773,160 | 223,082 | 735,492 | ||
| Previous Close | 3.43 | 4.40 | 1.3700 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 2.97 | 4.44 | 1.3728 | ||
| 20-Day Raw Stochastic | 85.58% | 40.40% | 77.59% | ||
| 20-Day Relative Strength | 57.59% | 45.73% | 52.40% | ||
| Weighted Alpha | -32.40 | -49.21 | -0.75 | ||
| Today's Opinion | N/A | 8% Buy | 56% Buy | ||
| Previous Opinion | N/A | 8% Buy | 24% Buy | ||
| Last Month's Opinion | N/A | 40% Buy | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +10.53% since 12/04/18 | -3.10% since 05/08/24 | +7.14% since 05/08/24 | ||
| Low | 2.95 on 12/06/18 | 4.14 on 05/10/24 | 1.2000 on 05/10/24 | ||
| High | 3.51 on 12/11/18 | 4.77 on 05/15/24 | 1.4700 on 05/15/24 | ||
| 1-Month | |||||
| %Chg | +16.26% since 11/12/18 | -2.24% since 04/15/24 | +1.79% since 04/15/24 | ||
| Low | 2.47 on 11/21/18 | 3.97 on 04/25/24 | 1.2000 on 05/10/24 | ||
| High | 3.51 on 12/11/18 | 4.96 on 05/03/24 | 1.4900 on 05/03/24 | ||
| 3-Month | |||||
| %Chg | +12.37% since 09/12/18 | -24.39% since 02/15/24 | -0.35% since 02/15/24 | ||
| Low | 2.47 on 11/21/18 | 3.97 on 04/25/24 | 1.2000 on 05/10/24 | ||
| High | 3.65 on 11/09/18 | 7.01 on 03/05/24 | 1.7850 on 03/11/24 | ||
| 6-Month | |||||
| %Chg | -33.60% since 06/12/18 | +140.11% since 11/15/23 | +34.43% since 11/15/23 | ||
| Low | 2.47 on 11/21/18 | 1.75 on 11/24/23 | 1.0100 on 11/16/23 | ||
| High | 5.30 on 06/20/18 | 7.01 on 03/05/24 | 1.7850 on 03/11/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 343,997 | 345,479 | 341,019 | ||
| Shares Outstanding, K | 102,380 | 78,518 | 248,919 | ||
| Annual Sales | 60,640,000 | 0 | 6,230,000 | ||
| Annual Net Income | -163,440,000 | -124,080,000 | -95,900,000 | ||
| Last Quarter Sales | 28,040,000 | 0 | 1,230,000 | ||
| Last Quarter Net Income | -17,000,000 | -29,940,000 | -33,060,000 | ||
| 60-Month Beta | 2.35 | 2.61 | 1.77 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.26 on 02/07/18 | -0.40 on 03/18/24 | -0.09 on 03/19/24 | ||
| Latest Earnings Date | 02/06/19 | 05/15/24 | 05/14/24 | ||
| Most Recent Dividend | N/A | N/A | 0.162 on 06/09/15 | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||